arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2210.13310stat.APstat.ML
收藏

机器学习在药物基因组学中的应用:血浆浓度-时间曲线聚类

Applications of Machine Learning in Pharmacogenomics: Clustering Plasma Concentration-Time Curves

Jackson P. Lautier, Stella Grosser, Jessica Kim, Hyewon Kim, Junghi Kim

AI总结:

本研究探索药代动力学(PK)曲线的无监督聚类方法,对比多种时间序列不相似性度量,发现欧氏距离最适用,且基于欧氏距离的聚类无需遗传信息即可验证既往药物基因组学结论,还能挖掘群体统计难以发现的规律。

摘要:

药物研究人员一直在寻找能够同时优化药物开发流程和改善患者预后的技术。近期备受关注的一个方向是机器学习(ML)在药理学中的应用潜力。其中尚未得到深入研究的一类应用是血浆浓度-时间曲线(下文称为药代动力学(PK)曲线)的无监督聚类。本文中,我们展示了关于如何依据相似度对PK曲线进行聚类的研究结果。具体而言,我们发现聚类能够有效识别形状相似的PK曲线,且有助于理解每个PK曲线簇内的模式。由于PK曲线属于时间序列数据对象,我们的方法以时间序列数据聚类相关的大量研究成果为基础。为此,我们研究了多种时间序列数据对象间的不相似性度量方法,以筛选出最适合PK曲线的度量方式。我们发现欧氏距离通常最适用于PK曲线聚类,同时进一步表明动态时间规整、Fréchet距离以及基于结构的不相似性度量(如相关性)可能会产生不符合预期的结果。作为示例,我们将这些方法应用于一项包含250条PK曲线的案例研究中,这些曲线曾用于此前的一项药物基因组学研究。我们的案例研究发现,采用欧氏距离的无监督ML聚类在不使用任何受试者遗传信息的情况下,能够独立验证出与参考药物基因组学研究结果一致的结论。据我们所知,这是首次实现此类验证。此外,该案例研究表明,PK曲线聚类能够产生仅通过PK指标的群体水平汇总统计难以发现的洞见。

英文摘要:

Pharmaceutical researchers are continually searching for techniques to improve both drug development processes and patient outcomes. An area of recent interest is the potential for machine learning (ML) applications within pharmacology. One such application not yet given close study is the unsupervised clustering of plasma concentration-time curves, hereafter, pharmacokinetic (PK) curves. In this paper, we present our findings on how to cluster PK curves by their similarity. Specifically, we find clustering to be effective at identifying similar-shaped PK curves and informative for understanding patterns within each cluster of PK curves. Because PK curves are time series data objects, our approach utilizes the extensive body of research related to the clustering of time series data as a starting point. As such, we examine many dissimilarity measures between time series data objects to find those most suitable for PK curves. We identify Euclidean distance as generally most appropriate for clustering PK curves, and we further show that dynamic time warping, Fréchet, and structure-based measures of dissimilarity like correlation may produce unexpected results. As an illustration, we apply these methods in a case study with 250 PK curves used in a previous pharmacogenomic study. Our case study finds that an unsupervised ML clustering with Euclidean distance, without any subject genetic information, is able to independently validate the same conclusions as the reference pharmacogenomic results. To our knowledge, this is the first such demonstration. Further, the case study demonstrates how the clustering of PK curves may generate insights that could be difficult to perceive solely with population level summary statistics of PK metrics.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑